Baseline Laboratory Testing Before Obesity Treatment
All patients should undergo comprehensive laboratory screening including complete blood count, haematinics (ferritin, folate, B12), vitamin D, calcium, PTH, HbA1c, fasting lipid panel, and liver/renal function tests before initiating any obesity treatment, with additional micronutrient testing (vitamin A, zinc, copper, selenium) specifically for those undergoing malabsorptive bariatric procedures. 1
Essential Laboratory Tests for All Patients
Haematological Assessment
- Complete blood count with hemoglobin to detect anemia (present in 19-47% of bariatric candidates) 1, 2
- Ferritin - iron deficiency occurs in 24-40% preoperatively, more common in women 1, 2
- Folate - deficiency ranges 0-63% in surgical candidates 1
- Vitamin B12 - deficiency present in 0-23% preoperatively 1
Bone and Mineral Metabolism
- 25-hydroxyvitamin D - deficiency reported in up to 99% of patients with severe obesity 1
- Serum calcium (albumin-adjusted) 1
- Parathyroid hormone (PTH) - elevated in 23-39% of candidates; if both PTH and calcium are elevated, suspect primary hyperparathyroidism and refer to specialist 1
Cardiometabolic Screening
- HbA1c - essential for diabetes screening and establishing baseline glycemic control 1, 3
- Fasting plasma glucose - consider oral glucose tolerance test if diabetes suspected 1
- Fasting lipid panel (total cholesterol, LDL, HDL, triglycerides) 4
Organ Function
- Liver function tests (AST, ALT) - to assess for NAFLD, present in most patients with obesity 1
- Renal function (serum creatinine, eGFR) 1
- Electrolytes/comprehensive metabolic panel 3
Additional Testing for Specific Procedures
For Malabsorptive Procedures (BPD/DS, RYGB)
Consider checking these before malabsorptive surgery due to higher postoperative deficiency risk 1:
- Vitamin A (though preoperative deficiency prevalence is low)
- Zinc (deficiency reported in up to 73.9% in some studies)
- Copper (deficiency up to 63.8%)
- Selenium
Discretionary Testing
Not routinely recommended unless clinical suspicion exists 1:
- Thiamine - insufficient evidence for routine screening, though some patients have low levels
- Magnesium - low prevalence of deficiency preoperatively
Critical Pitfalls to Avoid
Diabetes Classification
In insulin-treated patients, measure C-peptide and islet cell antibodies to distinguish type 1 from type 2 diabetes 5. This is crucial because:
- Type 1 diabetes patients will not achieve remission after bariatric surgery
- Risk of postoperative diabetic ketoacidosis in misclassified type 1 patients
- Clinical characteristics alone are insufficient for accurate classification
Primary Hyperparathyroidism
Always measure both PTH and calcium together 1. Elevated calcium with elevated PTH indicates primary hyperparathyroidism requiring specialist evaluation before surgery.
Preoperative Optimization
Correct all identified nutritional deficiencies before surgery 1, 4, 6. Patients have increased risk of postoperative deficiencies, and preoperative correction improves outcomes.
Rationale for Comprehensive Screening
The evidence consistently demonstrates that micronutrient deficiencies are extremely common in patients with obesity seeking treatment 7, 8, 2:
- Multiple deficiencies often coexist in the same individual
- Despite excess caloric intake, micronutrient intake is typically below recommendations
- No standard profile predicts who will have deficiencies
- Deficiencies relate to poor diet quality, not just quantity
For intensive lifestyle therapy and medication: The same baseline labs establish cardiometabolic risk, identify obesity-related complications requiring treatment, and provide benchmarks for monitoring treatment response 3.
For bariatric surgery: These tests are mandatory to optimize preoperative status, predict postoperative needs, and establish baselines for lifelong monitoring 1, 4.